Please login to Zacks.com or register to post a comment.
They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.
Today, you can see them free.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| SCIENTIFIC L | SCIL | 8.00% |
| NATUS MEDICA | BABY | 6.11% |
| SUMMER INFAN | SUMR | 6.02% |
| RADIANT LOGI | RLGT | 5.32% |
| NEW ORIENTAL | EDU | 4.51% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
Cirrus Logic Inc. ( CRUS - Snapshot Report ) reported third quarter 2013 adjusted earnings of $1.55 per share, surpassing the Zacks Consensus Estimate of $1.34. Adjusted or non-GAAP earnings per share exclude amortization of acquisition-related intangible assets, but include stock-based compensation expenses.
Revenue
Total revenue for the third quarter soared 153.4% from the year-ago quarter to $310.1 million, boosted by higher sales of Apple Inc.’s ( AAPL - Analyst Report ) iPhone 5, which generated good demand for the company’s products. Apple takes parts from Cirrus logic to manufacture its audio products. That’s a healthy part of the company’s business, and overall we see a big opportunity to continue to increase the company’s audio revenue.
Segment wise, Audio Product revenue surged 184.6% year over year to $300.0 million while Energy product revenue came in at $10.1 million, down 40.3% year over year.
Operating Results
Reported gross margin in the quarter was 51.0% versus 54.0% in the year-ago quarter as a result of higher costs.
Operating margin was 34.2% versus 21.6% in the year-ago quarter. The company’s total operating expenses increased 96.7% on a year-over-year basis. Higher operating expenses were mainly due to 27.9% and 15.4% year-over-year increases in research and development (R&D) and selling, general and administrative (SG&A) expenses, respectively.
Net income on a GAAP basis was $67.9 million or 99 cents per diluted share compared with $16.7 million or 25 cents in the year-ago quarter.
Excluding the amortization of acquisition-related intangible assets but including stock-based compensation expense, non-GAAP net income for the third quarter was $1.55 per diluted share compared with 39 cents in the year-ago quarter.
Balance Sheet
Cash and short-term investments were $87.5 million versus $67.8 million in the previous quarter. The company has no long-term debt.
Outlook
Management has provided upbeat outlook for the fourth quarter. The company expects revenues to be between $200.0 million and $220.0 million. Gross margin is expected to be between 50.0% and 52.0%. Combined R&D and SG&A expenses are expected in the range of $49 million to $51 million.
Our Take
Cirrus posted a stellar third quarter, with the bottom line comprehensively beating the Zacks Consensus Estimate. Expecting the momentum to persist, Cirrus provided decent fourth quarter guidance, which was enough to encourage the investors.
We remain optimistic about the strong demand for its analog and mixed-signal integrated circuits for audio products.
Though stiff competition from the likes of Texas Instruments Inc. ( TXN - Analyst Report ) , STMicroelectronics ( STM - Snapshot Report ) , ON Semiconductor ( ONNN - Analyst Report ) and Maxim Integrated Products ( MXIM - Analyst Report ) are concerns, good support from Apple Inc will help the company in the long run.
The company has a Zacks Rank #3 (Hold).
Read the full reports :
Snapshot Report on CRUS
Snapshot Report on STM
Analyst Report on MXIM
Analyst Report on TXN
Analyst Report on AAPL
Analyst Report on ONNN